-
1.Use of a norepinephrine reuptake inhibitor for the treatment of conduct disorder 审中-公开
标题翻译: 使用去甲肾上腺素摄取Inhibitores为品行障碍的治疗公开(公告)号:EP0919235A1
公开(公告)日:1999-06-02
申请号:EP98307630.8
申请日:1998-09-21
IPC分类号: A61K31/535 , A61K31/38 , A61K31/135
CPC分类号: A61K31/137 , A61K31/00 , A61K31/135 , A61K31/5375
摘要: Norepinephrine reuptake inhibitors are used to treat conduct disorder.
摘要翻译: 去甲肾上腺素再摄取抑制剂用于治疗行为障碍。
-
2.Use of reboxetine for the treatment of attention-deficit/hyperactivity disorder 审中-公开
标题翻译: 使用瑞波西汀的注意力缺失/多动症的治疗公开(公告)号:EP0909561A2
公开(公告)日:1999-04-21
申请号:EP98307657.1
申请日:1998-09-21
IPC分类号: A61K31/535
CPC分类号: A61K31/5375
摘要: Reboxetine is used to treat attention-deficit/hyperactivity disorder.
摘要翻译: 瑞波西汀是用来治疗注意力缺失/多动症。
-
3.Use of a norepinephrine uptake inhibitor for the treatment of oppositional defiant disorder 审中-公开
标题翻译: 使用去甲肾上腺素摄取Inhibitores为相对地违抗性障碍的治疗公开(公告)号:EP0919236A1
公开(公告)日:1999-06-02
申请号:EP98307650.6
申请日:1998-09-21
IPC分类号: A61K31/535 , A61K31/38 , A61K31/135
CPC分类号: A61K31/5375 , A61K31/00 , A61K31/135 , A61K31/137 , A61K31/138 , A61K31/165 , A61K31/381
摘要: Norepinephrine reuptake inhibitors are used to treat oppositional defiant disorder.
摘要翻译: 去甲肾上腺素再摄取抑制剂用于治疗对立违抗性障碍。
-
4.Use of duloxetine or of N-alkyl-3-phenyl-(2-alkylthiophenoxy)-propylamines for treating attention-deficit/hyperactivity disorder 失效
标题翻译: 使用度洛西汀(2- alkylthiophenoxy)-Propylaminen的或N-烷基-3-苯基的用于注意缺陷多动障碍的治疗公开(公告)号:EP0756869A2
公开(公告)日:1997-02-05
申请号:EP96305346.7
申请日:1996-07-22
发明人: Heiligenstein, John Harrison , Laguzza, Bennett Coleman , Paul, Steven Marc , Tollefson, Gary Dennis
IPC分类号: A61K31/135 , A61K31/38
CPC分类号: A61K31/381 , A61K31/138
摘要: A group of propanamines, norepinephrine uptake inhibitors, are used to treat attention-deficit/hyperactivity disorder.
摘要翻译: A组丙烷cardamines,去甲肾上腺素摄取抑制剂,被用于治疗注意缺陷/多动障碍。
-
5.Use of tomoxetine for the treatment of attention deficit/hyperactivity disorder 失效
标题翻译: 使用托莫西汀治疗与注意力障碍多动症公开(公告)号:EP0721777B1
公开(公告)日:2002-08-28
申请号:EP96300157.3
申请日:1996-01-09
IPC分类号: A61K31/138 , A61P25/00
CPC分类号: A61K31/138
-
6.Use of duloxetine or of N-alkyl-3-phenyl-(2-alkylthiophenoxy)-propylamines for treating attention-deficit/hyperactivity disorder 失效
标题翻译: 使用度洛西汀(2- alkylthiophenoxy)-Propylaminen的或N-烷基-3-苯基的用于注意缺陷多动障碍的治疗公开(公告)号:EP0756869A3
公开(公告)日:1999-06-16
申请号:EP96305346.7
申请日:1996-07-22
发明人: Heiligenstein, John Harrison , Laguzza, Bennett Coleman , Paul, Steven Marc , Tollefson, Gary Dennis
IPC分类号: A61K31/135 , A61K31/38
CPC分类号: A61K31/381 , A61K31/138
摘要: A group of propanamines, norepinephrine uptake inhibitors, are used to treat attention-deficit/hyperactivity disorder.
-
7.Use of reboxetine for the treatment of attention-deficit/hyperactivity disorder 审中-公开
标题翻译: 瑞波西汀用于治疗注意力缺陷/多动症公开(公告)号:EP0909561A3
公开(公告)日:1999-05-06
申请号:EP98307657.1
申请日:1998-09-21
IPC分类号: A61K31/535
CPC分类号: A61K31/5375
摘要: Reboxetine is used to treat attention-deficit/hyperactivity disorder.
摘要翻译: 瑞波西汀用于治疗注意力缺陷/多动症。
-
8.Use of tomoxetine for the treatment of attention deficit/hyperactivity disorder 失效
标题翻译: 使用托莫西汀治疗与注意力障碍多动症公开(公告)号:EP0721777A3
公开(公告)日:1997-03-05
申请号:EP96300157.3
申请日:1996-01-09
IPC分类号: A61K31/135
CPC分类号: A61K31/138
摘要: Tomoxetine, a norepinephrine uptake inhibitor, is used to treat attention-deficit/hyperactivity disorder.
-
9.Use of tomoxetine for the treatment of attention deficit/hyperactivity disorder 失效
标题翻译: 使用托莫西汀治疗与注意力障碍多动症公开(公告)号:EP0721777A2
公开(公告)日:1996-07-17
申请号:EP96300157.3
申请日:1996-01-09
IPC分类号: A61K31/135
CPC分类号: A61K31/138
摘要: Tomoxetine, a norepinephrine uptake inhibitor, is used to treat attention-deficit/hyperactivity disorder.
摘要翻译: 托莫西汀,去甲肾上腺素摄取抑制剂,用于治疗注意力缺失/多动症。
-
-
-
-
-
-
-
-